Jon Congleton
Vorstandsvorsitzender bei MINERALYS THERAPEUTICS, INC.
Vermögen: 16 Mio $ am 30.04.2024
Aktive Positionen von Jon Congleton
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | 01.11.2020 | - | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Private Equity Investor | - | - |
Karriereverlauf von Jon Congleton
Ehemalige bekannte Positionen von Jon Congleton
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IPI LEGACY LIQUIDATION CO | Direktor/Vorstandsmitglied | - | 05.05.2020 |
| Vorstandsvorsitzender | 03.10.2017 | 05.05.2020 | |
| Präsident | 03.10.2017 | 05.05.2020 | |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | Direktor/Vorstandsmitglied | 22.12.2014 | 15.01.2017 |
| Vorstandsvorsitzender | 22.12.2014 | 15.01.2017 | |
| Präsident | 22.12.2014 | 15.01.2017 | |
| ALPINE IMMUNE SCIENCES, INC. | Vorstandsvorsitzender | - | 01.01.2017 |
| Präsident | - | 01.01.2017 | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Vertrieb & Marketing | - | - |
Teva Neuroscience, Inc.
 Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Teva Neuroscience, Inc. developed and marketed drugs for neurological disorders. The company's product COPAXONE was used to reduce relapses caused by relapsing-remitting multiple sclerosis. It also offered treatment for Parkinson's disease. Teva Neuroscience was founded in 1997 and was located in Kansas City, MO | Corporate Officer/Principal | 19.11.2010 | - |
Ausbildung von Jon Congleton
| Kansas State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Israel | 2 |
| Japan | 2 |
Operativ
| Chief Executive Officer | 4 |
| Director/Board Member | 3 |
| President | 3 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| IPI LEGACY LIQUIDATION CO | Health Technology |
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Teva Neuroscience, Inc.
Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Teva Neuroscience, Inc. developed and marketed drugs for neurological disorders. The company's product COPAXONE was used to reduce relapses caused by relapsing-remitting multiple sclerosis. It also offered treatment for Parkinson's disease. Teva Neuroscience was founded in 1997 and was located in Kansas City, MO | Health Technology |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | Health Technology |
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Finance |
- Börse
- Insiders
- Jon Congleton
- Erfahrung
